Search research articles
Contact Us
Filters
Showing results (361-370 of 371) with videos related to
Page
of 38
Sort By:
Cancer Cell
|
May 8, 2026
Dendritic cell redundancy enables priming of anti-tumor CD4<sup>+</sup> T cells in pancreatic cancer
Courtney T S Kureshi, Michael J Walsh, Rakeeb Kureshi, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2026
A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2
Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun, et al.
JCO Precision Oncology
|
September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer
Rishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2024
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
Harshabad Singh, Pranshu Sahgal, Kevin Kapner, et al.
Cancer Immunology Research
|
July 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 20, 2026
Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identification
Karl Semaan, Marc Eid, Damien Vasseur, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
April 18, 2024
Molecular Transducers of Physical Activity Consortium (MoTrPAC): human studies design and protocol
, John M Jakicic, Wendy M Kohrt, et al.
The American Journal of Clinical Nutrition
|
February 6, 2019
Disentangling the genetics of lean mass
David Karasik, M Carola Zillikens, Yi-Hsiang Hsu, et al.
Nature Communications
|
July 21, 2017
Large meta-analysis of genome-wide association studies identifies five loci for lean body mass
M Carola Zillikens, Serkalem Demissie, Yi-Hsiang Hsu, et al.
Page
of 38
Search research articles
Search
Showing results (361-370 of 371) with videos related to
Sort By:
Page
of 38
Cancer Cell
|
May 8, 2026
Dendritic cell redundancy enables priming of anti-tumor CD4<sup>+</sup> T cells in pancreatic cancer
Courtney T S Kureshi, Michael J Walsh, Rakeeb Kureshi, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2026
A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2
Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun, et al.
JCO Precision Oncology
|
September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer
Rishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2024
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer
Harshabad Singh, Pranshu Sahgal, Kevin Kapner, et al.
Cancer Immunology Research
|
July 11, 2024
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 20, 2026
Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identification
Karl Semaan, Marc Eid, Damien Vasseur, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
April 18, 2024
Molecular Transducers of Physical Activity Consortium (MoTrPAC): human studies design and protocol
, John M Jakicic, Wendy M Kohrt, et al.
The American Journal of Clinical Nutrition
|
February 6, 2019
Disentangling the genetics of lean mass
David Karasik, M Carola Zillikens, Yi-Hsiang Hsu, et al.
Nature Communications
|
July 21, 2017
Large meta-analysis of genome-wide association studies identifies five loci for lean body mass
M Carola Zillikens, Serkalem Demissie, Yi-Hsiang Hsu, et al.
Page
of 38